Search Results 111-120 of 8404 for TNF

  1. Researchers explore whether senescence-associated secretory phenotype (SASP) is a potential driver of age-related dysfunction - Mayo Clinic

    Growth differentiation factor 15 (GDF15) · Tumor necrosis factor receptor superfamily member 6 (TNFRSF6) · Osteopontin (OPN) · TNF receptor 1 (TNFR1) · Activin A ...

  2. Publications - Lester E. Mertz, M.D. - Mayo Clinic

    ... Tumor Necrosis Factor alpha. Clin Infect Dis. 2019 Mar 5; 68 (6):1024-1030. View PubMed; Nokes B, Tseng AS, Cartin-Ceba R, Shamoun F, Jokerst C, Mertz L ...

  3. Publications - Shannon P. Fortin Ensign, M.D., Ph.D. - Mayo Clinic

    Tumor necrosis factor-like weak inducer of apoptosis stimulation of glioma cell survival is dependent on Akt2 function. Mol Cancer Res. 2009 Nov; 7: (11)1871-81 ...

  4. Overview - Translational Polycystic Kidney Disease (PKD) Center - Mayo Clinic Research

    His research laboratory focuses on epigenetics, TNF-alpha and inflammatory signaling, and senescence in PKD, among other mechanisms. Funding. The Mayo Clinic ...

  5. A Study to Evaluate Safety and Effectiveness of SHP647 as Induction Therapy in Participants with Moderate-to- Severe Crohn's Disease - Mayo Clinic

    ... TNF. Subjects who have had an inadequate response to sulfasalazine or mesalamine should have also failed at least 1 other conventional treatment such as ...

  6. Neoadjuvant Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Cutaneous Stage L-lll Melanoma - Mayo Clinic

    Immunosuppressive mediations (steroids, tumor necrosis factor (TNF)-inhibitors, azathioprine, etc.) within the past 6 weeks; Active or chronic infection with ...

  7. Publications - Timothy R. Aksamit, M.D. - Mayo Clinic

    Dexamethasone inhibits IL-1 and TNF activity in human lung fibroblasts without affecting IL-1 or TNF receptors. Am J Physiol. 1994 Jul; 267(1 Pt 1):L33-8 ...

  8. Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of AS - Mayo Clinic

    Exposure to more than 1 TNF-antagonist or primary failure to TNF antagonist therapy; History of or current chronic or recurrent infections; Subjects with ...

  9. David A. Wetter, M.D. - Mayo Clinic Faculty Profiles

    Paradoxical autoimmune side effects of tumor necrosis factor-alpha inhibitors, including psoriasis, lupus and vasculitis. Significance to patient care. Dr ...

  10. Treatment of Proteinuria Due to Treatment Resistant or Treatment Intolerant Idiopathic FSGS - Mayo Clinic

    ... Tumor Necrosis Factor-Alpha Therapy (anti-TNF α) agent. -Effective contraception from screening, and for 36 weeks after the last dose of investigational ...